World

More positive news on the COVID-19 vaccine front (NYSE: AZN)

The Oxford Covid-19 vaccine supported by AstraZeneca (NYSE: AZN) it’s generating the kind of antibody and T-cell (killer cell) response that researchers would expect to see, reports Robert Peston, saying the first data will be published soon in The lancet. That said, efficacy will only be adequately established in the …

Read More »